The results tend to support this hypothesis, as the corticotectal projection was moderately affected (decreased) after M1 lesion (only when anti-Nogo-A antibody treated), whereas there was no consistent change in PD monkeys with ANCE treatment. This evidence concerns the gene RTN4 and Parkinson disease.